Back pain is the leading cause of disability worldwide. When physical therapy, medications, and injections fail, spinal fusion may be the answer. The spinal fusion market report by MRFR shows that interbody cages are the largest product segment, and the market is growing at 5.8% CAGR — from $10.9 billion to $20.27 billion by 2035. Why the steady rise? Because the population is aging, and we're getting better at spine surgery.

What's driving growth? Posterolateral fusion is the largest procedure, but interbody fusion is the fastest‑growing. The spinal fusion market analysis highlights that hospitals are the dominant end‑user, but specialty clinics are growing fast — as spine surgery moves to outpatient settings.

What's new? Minimally invasive spinal fusion (MIS) through tiny incisions, preserving muscles and speeding recovery. Also, 3D‑printed titanium cages that match the patient's anatomy perfectly.

The bottom line: spinal fusion is not a first‑line treatment, but for the right patient (instability, deformity, severe disc degeneration), it can be life‑changing. If you're considering surgery, get a second opinion from a spine specialist.